Thyrotoxicosis in childhood is uncommon and there are few reports regarding either its treatment or prognosis. There is no agreement on whether medical or surgical therapy is better. Arnold, Talbot, and Cope (1958) summarized the choice as follows.
(a) Surgical excision: short in duration, but carrying a mortality risk and the possibilities of recurrence or hypothyroidism.
(b) Medical therapy: frequent and prolonged, with the need for supervision, the risk of toxic reactions, and the chance of eventual failure.
Surgical mortality may be small but is present in most of the recQrded series (Hayles, Kennedy, Beahrs, and Woolner/ 1959; Kunstadter and Stein, 1955; McClintock, Frawley, and Holden, 1956; Van Wyk, Grumbach, Shepard, and Wilkins, 1956 ) where a total of 7 children died after 275 operations. Arnold et al. (1958) and Root, Bongiovanni, Harvie, and Eberlein (1963) had no mortality in 28 patients. In all these series the recurrence rate was not less than 5%, while no less than 73 children operated on were subsequently found to be hypothyroid. On the other hand some patients were submitted to operation only because medical therapy had failed.
Medical therapy carries few risks. There are few reports of toxic drug reactions in children who seem to be at less risk than adults. Kunstadter and Stein (1955) had no reactions in 17 children treated with thiourea derivatives; Hung, Wilkins, and Blizzard (1962) reported maculo-papular rashes and fever in 2 of 9 children treated with perchlorate, urticarial rashes in 3 of 23 children who had propylthiouracil, and 'granulocytopenia accompanied by buccal ulceration and sore throat' in 1 of these children; Root et al. (1963) noted that 3 of their 17 children had mild leucopenia with fever and a skin rash.
With these 9 and one child in the present series who developed leucopenia while on a small dose of methylthiouracil, there were, therefore, 10 children out of 99 treated who developed toxic reactions. This figure is similar to the incidence (2-10%) reported in adults.
In some reported series medical therapy has had to be abandoned because of the lack of co-operation by patient or parents. Though this did not occur in the present study, it may have to be considered an important factor influencing the choice of therapy.
As nearly all patients respond to some antithyroid drug, the duration of medical therapy may be the main factor dictating the choice between medical or surgical therapy. There is little recorded experience of this yet. Hung et al. (1962) suggest that probably over one-third of thyrotoxic children are cured by therapy lasting for two years or more.
In the decade 1953-63, 26 children attended The Hospital for Sick Children with thyrotoxicosis. With the records of 7 other children seen before 1953, they are here reviewed in an attempt to assess the therapy of this condition in childhood.
Of the 33 children, 29 were girls and 4 were boys. Symptoms appeared before the age of 5 years in 10 patients, between 5 and 10 years in 14 patients, and between 10 and 14 years in 9. It is likely that the last figure is artificially low because some children with onset at this age are referred to adult units. The duration of symptoms before the diagnosis was made is shown in Table 1 .
There was no relation between the age of the child and the delay in diagnosis. The shortest history was 2 weeks, the longest 19 months. The long delay in diagnosis in nearly one-third of McKENDRICK AND NEWNS the series reflects, as in adults, the difficulty of differentiating the insidious onset of thyrotoxicosis from longstanding behaviour, and emotional disturbances, and anxiety states. The occurrence of other thyroid disorders in the families did not always reduce this delay. Of 11 families, 17 members had thyroid abnormalities of some kind, i.e. either goitre or thyrotoxicosis; these included 6 parents, 3 grandparents, and 8 aunts or cousins. The symptom of personality change merits special attention. As a presenting feature it was uncommon. Closer inquiry, however, elicited that in 13 children abnormal behaviour had been noted for some years, often beginning long before any other symptom appeared. Only in retrospect did the parents recognize that such behaviour change had become more marked when other symptoms began. Since behaviour problems sufficiently marked to require medical advice occur in about 5 to 10% of children,* it is difficult to know how much of these features could be attributed to hyperthyroidism. There was no specific pattern. Misbehaviour, lack of concentration, bullying, 'not trying' and backwardness at school, perversity, wilfulness and temper tantrums at home, as well as enuresis, and other symptoms of being 'highly strung' were recorded. Recovery from them was sometimes dramatic when thyrotoxicosis was controlled but it was not always either rapid or complete. The first symptom of a relapse was usually behaviour disorder. In most patients signs were sufficiently clear to confirm the diagnosis suggested by the history. Most were similar to those seen in adults. Thus 30 patients had an abnormal tachycardia and 21 an unusually high pulse pressure; warm moist palms were noted in 26 patients. Prominent eyes, whether due to lid retraction or exophthalmos were obvious in 23 and present in another 4 patients but absent in 6. Lid lag and other ocular signs could be demonstrated in 14 patients, usually in the older age-groups. Only 2 patients had no abnormal movements. Though tremor was commonly recorded it was seldom of the classical thyrotoxic fine type. Choreiform movements were seen in 7 patients. Anxiety, nervousness, restlessness, and fidgeting were evident in 25.
The accelerated growth associated with hyperthyroidism is shown in Table 3 . It will be noted that excessive height was common but that nearly half the children were able to eat enough to keep their weight approximately commensurate with height.
All the patients had an enlarged thyroid gland, but in 4 this was very slight and only in 2 was it described as large. All the glands were smooth, most were symmetrical, and over most a bruit was heard.
Investigations
. Estimation of the blood cholesterol was unhelpful.
In 5 patients the level was over 200 mg./100 ml.; in 16 it was within the normal range of 100-200 mg./100 ml., and in 1 it was low.
The basal metabolic rate (BMR) was measured in 24 patients. In 8 it was unequivocally raised, i.e. over 140% of the normal levels related to surface area; in 8 it was less clearly raised, i.e. between 120 and 140% and in 8 it was hardly abnormal, i.e. 100 to 120%. In no child was it less than 100%. In one other child, lack of co-operation twice prevented any worth-while measurement. There was considerable discrepancy (over 30%) between duplicate measurements in three children. these, 9 had high levels (greater than 8 ,ug./100 ml.), and 3 had normal levels (4-8 ,.Lg./100 ml.), the lowest level being 5 * 5 ,ug./100 ml. The correlation between BMR and PBI in the 9 patients in which both were estimated was not high (see Table 4 ). Diagnosis In spite of the newer techniques, such as the study of radio-iodine uptake by the thyroid, measurement of BMR by diapherometry, and estimation of PBI, the diagnosis of thyrotoxicosis remains a clinical exercise. In none of the children in this series was the diagnosis suggested by any such investigation and the chief value of these tests was in confirming the diagnosis vis-a-vis psychological disorder more rapidly and certainly. They also enabled a more rational approach to the control of the condition by drug therapy; but they have not so far eased the problem of how long treatment should continue. Therapy Therapy is summarized in Table 5 . The early patients in this series were either subjected to partial thyroidectomy or were treated with sedation and prolonged bed-rest. Of the 4 who were operated on, 3 were known to have remained well (and euthyroid) for 61, 10k, and 20 years respectively, though one child developed an inactive thyroid adenoma. The fourth child was well 1 years later, after which she was lost to follow-up. This apparently favourable outlook must be tempered by the fate of 2 of the 5 children who were operated on after apparent failure of medical therapy: one died suddenly on the day after an Carbimazole. Table 7 summarizes the results with this drug in 15 patients.
All the patients except one treated with carbimazole became euthyroid within 3 months, and over half of them within one month. There seemed little difficulty in maintaining this state for several years but even after nearly 6 years of therapy, relapse could still occur while on therapeutic doses.
Five patients have remained euthyroid for more than a year after cessation of one course of therapy. The duration of the course, however, has varied from 3 to 39 months. Only one patient has relapsed after having stopped treatment for more than a year; 7 others have relapsed either within 9 months of cessation or while still on maintenance therapy. There is no relation between liability of relapse and duration of therapy or rapidity of control of symptoms.
Of these 15 patients, 4 became hypothyroid during therapy. Though they all had low serum PBI levels, only one showed clinical signs. Serial estimation of PBI level undoubtedly facilitated smoother control in the other 3 as well as those who relapsed. Perchlorate. This drug was introduced relatively recently and only 9 patients received sodium (or potassium) perchlorate (see Table 8 ). Though only one patient has so far been followed up for more than a year after treatment, this group suggests that perchlorate has little advantage over carbimazole. Of the 9 patients, one failed to respond to a moderate dose and subsequently responded quickly to carbimazole. All the others became euthyroid in less than 3 months (on average rather less than 2 months) irrespective of the dose given. So far 3 have relapsed, one while on perchlorate, the other 2 five months after stopping treatment.
Hypothyroidism as judged by serial PBI estimations has been commoner, occurring in 5 of the 9 patients.
Discussion
Therapy with anti-thyroid drugs was given to 25 patients. All except 3 were brought under control within 3 months and of the exceptions, 2 (E.H., Table 6 and J.C., Table 8 ) were inadequately treated; 7 have completed one or more courses lasting in all between 3 and 39 months and subsequently remained euthyroid for more than a year; 7 relapsed after completing up to 42 months therapy; with one exception all relapsed within a year of cessation of therapy and all except 2 had been treated for more than 2 years; 6 have relapsed while still on maintenance therapy, 2 more than once, and these relapses have been as early as 5 months or as late as 11 years after beginning treatment; 8 patients (including some Hung et al. (1962) and Root et al. (1963) the risk of 'breaking through' control especially if after long periods administration of the drug becomes less regular.
The scheme suggested by Root et al. seems the best compromise. Drugs are used for two years and then stopped. One relapse is treated similarly but any subsequent relapse is an indication for operation as are toxic drug reactions and lack of co-operation. It also seems reasonable to treat pre-pubertal patients medically even if this means more than 2 years of therapy.
Summary
In an attempt to assess the value of medical therapy of thyrotoxicosis in children, the progress of 33 children was studied. Most were girls and the onset of symptoms occurred at all ages after 4 years. The more valuable diagnostic features were nervousness, proptosis, goitre, tachycardia, sweating, and abnormal movements. Excessive growth was common. Abnormal behaviour tended to delay the diagnosis. Special investigations were of relatively slight value in the initial diagnosis but facilitated the later supervision.
One of 9 children treated by operation died; one more has relapsed. All except 1 of 23 who were given adequate medical therapy were controlled without difficulty. About one-third have remained euthyroid for over a year after the cessation of therapy. Similar proportions have relapsed either on maintenance therapy or within a year or so of its cessation. The slightly lower dosage of drugs used (compared with other series) may have accounted for this less satisfactory result and for the lower incidence of drug toxicity.
On the basis of this and other series it is suggested that a two-year course of medical therapy should be given in the first place. A relapse should be followed by a second course also lasting two years. Any further relapse should be treated by operation.
Thanks are due to the Physicians of The Hospital for Sick Children for permission to include patients under their care in this series.
